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Abstract
Background: The atrioventricular node (AVN) is a key component of the cardiac pacemaker-conduction system. Although it
is known that receptors for the peptide hormone endothelin-1 (ET-1) are expressed in the AVN, there is very little
information available on the modulatory effects of ET-1 on AVN electrophysiology. This study characterises for the first time
acute modulatory effects of ET-1 on AVN cellular electrophysiology.
Methods: Electrophysiological experiments were conducted in which recordings were made from rabbit isolated AVN cells
at 35–37uC using the whole-cell patch clamp recording technique.
Results: Application of ET-1 (10 nM) to spontaneously active AVN cells led rapidly (within ,13 s) to membrane potential
hyperpolarisation and cessation of spontaneous action potentials (APs). This effect was prevented by pre-application of the
ETA receptor inhibitor BQ-123 (1 mM) and was not mimicked by the ETB receptor agonist IRL-1620 (300 nM). In whole-cell
voltage-clamp experiments, ET-1 partially inhibited L-type calcium current (ICa,L) and rapid delayed rectifier K
+ current (IKr),
whilst it transiently activated the hyperpolarisation-activated current (If) at voltages negative to the pacemaking range, and
activated an inwardly rectifying current that was inhibited by both tertiapin-Q (300 nM) and Ba
2+ ions (2 mM); each of these
effects was sensitive to ETA receptor inhibition. In cells exposed to tertiapin-Q, ET-1 application did not produce membrane
potential hyperpolarisation or immediate cessation of spontaneous activity; instead, there was a progressive decline in AP
amplitude and depolarisation of maximum diastolic potential.
Conclusions: Acutely applied ET-1 exerts a direct modulatory effect on AVN cell electrophysiology. The dominant effect of
ET-1 in this study was activation of a tertiapin-Q sensitive inwardly rectifying K
+ current via ETA receptors, which led rapidly
to cell quiescence.
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Introduction
The atrioventricular node (AVN) is a small yet critically important
component of the cardiac pacemaker-conduction system that lies at
the junction between right atrium and ventricle [1,2]. It is normally
the only site where electrical activity can pass from atria to ventricles
[1,2]. Comparatively slow conduction through the AVN co-ordinates
the normal timing of atrial then ventricular excitation [2,3] and in the
setting of supraventricular tachycardias such as atrial fibrillation, this
limits impulse transmission to the ventricles [2,4]. On the other hand,
aberrant AVN conduction can itself lead to arrhythmia [2,5]. The
AVN also has pacemaking properties [2,5]. Normally these are
subordinate to the heart’s dominant pacemaker the sinoatrial node
(SAN); however, should the SAN fail the AVN can take over
pacemaking of the ventricles [2,5]. AVN pacemaking is incompletely
understood, but is established to involve an interplay between the
activity of a number of different ionic conductances [6–10].
Endothelin-1 (ET-1) is a potent vasoactive peptide hormone
that is produced constitutively within the heart by vascular and
endocardial endothelial cells. There is also evidence for ET-1
release by cardiac myocytes [11,12]. In addition to its vasocon-
strictor action, endogenous release of the hormone is known to
modulate the inotropic state of the heart and is also suggested to
play a role in modulation of the heart rate (e.g. [13–16]). Elevated
production and release of ET-1 is strongly implicated in the
pathogenesis of heart failure and the generation of arrhythmias
(for reviews see [17–19]). There is also evidence that ET-1 can be
pro-arrhythmic independent of coronary vasoconstriction [12,19].
Data from patients with angina pectoris have shown left bundle-
branch block to be associated with raised ET-1 levels, suggesting
that the hormone may be involved in conduction abnormalities
[20]. Consistent with an ability of ET-1 to exert a direct effect on
the pacemaker-conduction system, experiments on cells isolated
from the rabbit SAN have demonstrated that ET-1 produces a
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channel modulation [21–23].Bycontrast,toourknowledge, thereis
no current information available concerning direct effects of this
peptide hormone on the AVN. Autoradiographic studies of the
human myocardium have revealed a high density of
125I-ET-1
binding to the AVN and the penetrating and branching bundles of
His, in addition to the atrial and ventricular myocardium [24].
Autoradiographic study of the porcine AVN has also demonstrated
the presence of specific
125I-ET-1 binding sites in this region [25].
Indirect evidence that ET-1 can modulate AVN electrophysiology
comes from electrocardiogram measurements from anaesthetised
dogs and rats, which have shown that intra-coronary ET-1
administration can produce complete AV block [26,27]. Although,
when considered together, the effect of intra-coronary ET-1 and
evidence for presence of ET receptors in the AVN are strongly
suggestive of a direct action of ET-1 on AVN electrophysiology,
they are not conclusive in this regard. The present study was
therefore undertaken to address this gap in information, by using an
established rabbitsingle AVN cell preparation[6,28–32]. The study
was conducted to establish the effects of ET-1 on: (i) AVN cell
spontaneous activity and (ii) major ionic currents present in AVN.
Theresults thatemergedemonstrate that ET-1exertsmarkeddirect
effectson AVNcell electrophysiologyandalsoimplicate endothelin-
A (ETA) receptors in the observed modulatory actions.
Materials and Methods
Ethics statement
All procedures used in these experiments were approved by the
University of Bristol ethics committee and adhere to the United
Kingdom Home Office Animals Scientific Procedures Act of 1986.
Rabbit AVN cell isolation
Male New-Zealand White rabbits (,2.0 to 3.5 kg) were killed in
accord with UK Home Office legislation, their hearts then rapidly
excised and cells isolated from the entire atrioventricular nodal
(AVN) region using an established enzymatic and mechanical
dispersion technique [28,29;33]. Isolated AVN cells were sus-
pended in Kraft-Bru ¨he ‘‘KB’’ solution [28,34] and stored in a
refrigerator until use.
Electrophysiological recording
For recording, cells were transferred in KB solution into an
experimental chamber (0.5 ml) mounted on the stage of an
inverted microscope (Nikon Diaphot) and left to settle for 10 mins
prior to superfusion with a normal Tyrode’s solution, containing
(in mM): NaCl 140, KCl 4, CaCl2 2, MgCl2 1, HEPES 5 and
Glucose 10, (pH 7.4 with NaOH). ET-1 and other compounds
were added to this solution. Patch-pipettes (Corning 7052 glass,
AM Systems Inc, Sequim, WA, USA) were pulled using a P-97
Flaming/Brown micropipette puller (Sutter Instruments, Novato,
CA, USA) and filled with a solution containing (in mM) [10;33]:
KCl 110, NaCl 10, HEPES 10, MgCl2 0.4, and Glucose 5,
K2ATP dihydrate 5, GTP-Tris salt 0.5 (pH 7.1 with KOH). For
ionic current but not action potential measurements the pipette
solution also contained 5 mM BAPTA (cf [10,33]). Recordings
were made using an Axopatch 1D amplifier (Axon Instruments;
now Molecular Devices, Sunnyvale, CA, USA). Pipette resistance
was typically ,3M V; series resistance values were usually
,7M V (mean of 6.0760.68 MV; n=23) and ,60–80% of the
series resistance was compensated. Membrane capacitance values
used for calculation of current densities (pA/pF) were obtained
and compensated for using capacitance compensation on the
recording amplifier; cell capacitance values obtained in this way
have been shown previously to match closely those obtained using
a ‘surge’ technique [28]. For voltage clamp experiments,
membrane potential was held at 240 mV (as this corresponds to
the zero current potential for rabbit AVN cells [28,30]). Action
potentials were recorded from spontaneously beating cells in
current-clamp mode with zero-current injection, using a gap-free
Figure 1. Effects of ET-1 on spontaneous APs. A. Slow time-base recording of APs before, during and after rapid application of 10 nM ET-1. B.
Expanded (faster time-base) portions of the recording extracted from numbered sections of panel A (indicated labels i, ii, iii). Similar results were
observed in 9 experiments.
doi:10.1371/journal.pone.0033448.g001
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using Clampex 8 (Axon Instruments; now Molecular Devices
Sunnyvale, CA, USA). Data digitization rates were 10–25 kHz
with an appropriate bandwidth of 2–10 kHz set on the amplifier.
Solutions and Chemicals
Cells were superfused with experimental solutions at 35–37uC
(checked regularly using a hand-held thermocouple). ET-1 and
other compounds were applied externally to the cell under study
using a home-built, rapid solution exchange device capable of
exchanging superfusate in ,1 s [35]. ET-1 (Sigma-Aldrich
Company Ltd, Dorset, UK) was used at 10 nM from a stock
solution of 100 mM prepared in 0.1% acetic acid. This
concentration falls within the range of ET-1 concentrations used
in prior cardiomyocyte studies (1–100 nM; e.g. [21,23,36]). The
selective ETA receptor antagonist BQ-123 (Sigma-Aldrich Com-
pany Ltd, Dorset, UK) was used at a maximally effective
concentration of 1 mM [37] from a 1 mM stock solution made
in deionised water, whilst the endothelin-B receptor (ETB) selective
agonist IRL-1620 (Tocris Bioscience, Bristol, UK) [38] was
superfused at a concentration of 300 nM from a 1 mM stock
solution prepared in 0.1% acetic acid. Tertiapin-Q (Tocris
Bioscience, Bristol, UK) and barium ions (Ba
2+, as BaCl2,
(Sigma-Aldrich Company Ltd, Dorset, UK)) were prepared in
deionised water and respectively used at 300 nM and 2 mM. All
drugs were aliquoted and stored at 220uC, except BaCl2 solution,
which was stored at 4uC.
Data analysis
Data were analysed and graphical plots produced using
Clampfit 10.2 software (Molecular Devices Sunnyvale, CA,
USA), Microsoft Excel (2003), GraphPad Prism (v5; GraphPad
Software Inc, La Jolla, CA, USA), IgorPro (v3.16B, Wavemetrics
Inc, Portland, OR, USA) and SigmaPlot (v12; Systat Software Inc,
Chicago, IL, USA). Data are presented as mean 6 standard error
of the mean (SEM). Statistical analysis was performed using
Student’s t-test or two-way ANOVA with Bonferroni or Tukey
post-hoc tests, as appropriate. Values of ‘p’ less than 0.05 were
taken as significant.
Current-voltage relations for L-type Ca current (ICa,L) and rapid
delayed rectifier current (IKr) were fitted with following equations:
ICa,L~½Gmax(Vm{Vrev) =½1zexp((V0:5{Vm)=k) ð 1Þ
where Gmax is maximal ICa,L conductance, Vm is the test potential at
which ICa,L was measured, Vrev is the reversal potential determined
from extrapolation of the ascending limb of plotted current-voltage
relations, V0.5 is the potential at which ICa,L activation is half
maximal and k is the slope factor describing current activation.
Itail~Itail(Max)=(1zexp½(V0:5{Vm)=k ) ð2Þ
where Itail represents IKr tail current amplitude recorded at
240 mV following a given test pulse membrane potential (Vm) and
V0.5 and k have similar meanings to those for equation 1.
Results
Effects of ET-1 application on spontaneous APs
Spontaneous APs were measured in whole-cell membrane
potential recording mode from cells selected on the basis of
exhibiting regular spontaneous activity (evidenced visually as
regular spontaneous cell beating) during superfusion of control
Tyrode’s solution. Figure 1A shows a representative slow time-
base record of APs, before, during and following exposure to
10 nM ET-1, whilst Figures 1Bi–iii show faster time-base extracts
at the time-points indicated on Figure 1A. The mean spontaneous
AP rate in control solution was 3.4760.35 AP s
21 (n=9),
compatible with rates seen in previous studies [10,28,31,33]).
Application of ET-1 led rapidly to membrane potential hyperpo-
larisation and to cessation of spontaneous APs (within 13.162.1 s
of ET-1 application; n=9). As shown in Figure 1A, after reaching
an initial peak response (the mean peak membrane potential
hyperpolarisation produced by ET-1 in comparison to control
maximum diastolic potential values was 220.362.0 mV, n=9),
membrane potential showed gradual depolarisation but without a
return of spontaneous activity. As has been reported in some other
studies (e.g. [21,39]), the effect of ET-1 was not reversible on
washout and membrane potential continued to show modest
membrane potential depolarisation throughout the remainder of
the measurement period. In all cells, whilst on ET-1 application
cells rapidly ceased to generate spontaneous APs, small membrane
potential oscillations were visible (of mean amplitude
3.560.3 mV, n=9 cells; more than 25 oscillations analysed per
cell), with occasional oscillations exceeding 10 mV; see Figures 1A
and 1Bii and iii).
Effects of ET-1 on ionic currents at negative membrane
potentials
AVN cell sub-types exhibiting time-independent and time-
dependent current (If) on membrane potential hyperpolarisation in
standard extracellular solution have been identified [29,31]. The
effects of ET-1 were determined on cells with both response types.
Effects of ET-1 were determined by application of 500 ms
duration hyperpolarising voltage clamp commands: from a
holding potential of 240 mV membrane potential was stepped
to more negative potentials between 2120 and 240 mV in
10 mV increments (at a pulse frequency of 0.2 Hz). Figure 2Ai
shows current records elicited on membrane potential hyperpo-
larisation to 2120 mV, for a cell that exhibited only time-
independent current in control solution. On the application of
ET-1, holding current shifted outwards (in control, holding current
at 240 mV was 20.460.3 pA/pF, n=7, NSD from zero current;
in ET-1 this became 1.160.4 pA/pF; p,0.001 versus control). At
2120 mV a large inward current was induced, with a marked
increase in instantaneous inward current. Some time-dependence
of the current can be seen in this example. Figure 2Aii shows ET-1
sensitive (activated) current from the same cell, at 290, 2100 and
2120 mV. Outward holding current is visible prior to the marked
inward current elicited on membrane potential hyperpolarisation,
the amplitude of which increased progressively with the magnitude
Figure 2. Modulation by ET-1 of instantaneous current in cells lacking If. Ai. Currents recorded in the absence (control) and the presence of
10 nM ET at 2120 mV (upper traces) when a voltage command was applied from 240 mV for 500 ms (lower trace). Note outward shift in holding
current with ET-1. Closed circles indicate control trace; open circles indicate trace in ET-1. Aii. ET-1 activated currents (elicited at 290, 2100 and
2120 mV) obtained by digital subtraction of control from ET-1 records (same cell as Ai). B. Mean current-voltage (I–V) relationships for current
measured at the start of applied voltage commands in absence (control, filled circles) and presence (open circles) of 10 nM ET-1 (n=7). Asterisks
denote statistical significance (p,0.05 *, p,0.01 **, p,0.001 ***). C. Plot of the mean I–V relationship for ET-1 sensitive difference (ET-1 activated)
calculated from the same cells shown in B. D. Plot of ET-1 sensitive current when ET-1 was applied after 1 mM BQ-123 (n=4).
doi:10.1371/journal.pone.0033448.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33448Figure 3. ET-1 effects on the hyperpolarisation-activated current If. A. Upper traces show currents elicited 2120 mV in an If-expressing cell
in control solution and 10 nM ET-1 by protocol shown in bottom trace. Note outward shift in holding current in presence of ET-1. Closed circles
indicate control trace; open circles indicate trace in ET-1. B. Mean I–V relationships (n=7) for If, plotted as time-dependent current during command
pulses, in absence (control, filled circles) and presence of 10 nM ET-1 (open circles). The activating effect of ET-1 was significant only at 2120, 2110
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in augmenting time-independent (instantaneous) current was
quantified by plotting current density-voltage relations for
instantaneous current in control and in ET-1 (Figure 2B) and
also by deriving from individual experiments the ET-1 sensitive
difference (ET-1 activated) current, the mean of which is plotted in
Figure 2C. Net instantaneous current (Figure 2B) was augmented
by ET-1 across a range of potentials, with a left-ward shifted zero-
current potential compared to control; control and ET-1 current-
voltage relations intersected near 280 mV (Figure 2B). The ET-1
activated current (Figure 2C) showed marked inward rectification
and reversed at ,282 mV (with a mean reversal potential derived
from individual cell data of 282.161.2 mV; n=7). The activation
of this current accounts for the left-ward shift in zero current
potential for net instantaneous current visible in Figure 2B. The
ET-1 activated current was outwardly directed over potentials
relevant to the diastolic potential range (typically between 265
and 240 mV). The ET-1 response showed some time-dependent
‘fade’ in the continued presence of the peptide: the mean
amplitude of the ET-1 activated current at 2120 mV immediately
following (within 10–20 s) of ET-1 application was 27.260.7 pA/
pF (n=7), whilst at ,2 minutes following ET-1 this had declined
to 21.760.3 pA/pF (n=7; p,0.001 versus immediate response)
and in two cells that lasted ,3.5 minutes following ET-1 this was
20.660.2 pA/pF. In cells pre-treated with BQ-123, ET-1 did not
activate such a current: Figure 2D shows the instantaneous ET-1
sensitive difference current in cells exposed to BQ-123 prior to
ET-1 application. This implicates ETA receptor activation in the
observed response.
Figure 3 shows comparable data for cells that exhibited If in
control. Figure 3A shows representative currents in control
solution and in the presence of ET-1. A dual effect was seen, in
which both instantaneous and time-dependent current compo-
nents were augmented in the presence of ET-1. Previously, If from
AVN cells has been measured as the difference between end-pulse
current and instantaneous current observed at the start of the
hyperpolarising step [29,33] and this method was used here to
produce the mean I–V relations shown in Figure 3B. As reported
previously [29,33], under these conditions there was little If
between 260 and 280 mV in control Tyrode’s solution, whilst
significant If was evident at more negative voltages. In the presence
of ET-1, time-dependent current was significantly augmented at
potentials of 2100 mV and more negative than this (Figure 3B).
However, this response was transient: the mean amplitude of If at
2120 mV immediately following (within 10–20 s) of ET-1 was
24.360.6 pA/pF (n=7), whilst at ,2 minutes following ET-1
this was 21.960.7 pA/pF (n=7; p,0.001 versus the immediate
response), with the current at ,3.5 minutes following ET-1 similar
to that following 2 minutes of exposure. Figures 3Ci and Cii show
effects of ET-1 on the instantaneous current component (i.e.
comparable data to those shown in Figures 2B and 2C),
demonstrating that activation of an inwardly rectifying instanta-
neous current also occurred in these cells. Figure 3Ci shows mean
net instantaneous current in control and ET-1, again showing a
left-ward shift in zero-current potential and intersection of the two
relations close to 280 mV. Figure 3Cii shows the current-density
plot for ET-1 activated current, which resembles that in Figure 2C.
Note that the magnitude of the ET-1 activated current was not
significantly different from that from cells that lacked If, except at
2120 mV (p,0.01 at this potential only). Figure 3D shows plots
of time-dependent If in the presence of BQ-123 and BQ-123+ET-
1. These were closely superimposed, implicating ETA receptors in
the effect of ET-1 on If. Figure 3E shows that, similar to cells
lacking If (Figure 2), ET-1 failed to activate instantaneous inwardly
rectifying current in the presence of BQ-123.
Effects of ET-1 on ICa,L
Similar to other recent studies from our laboratories [10,33], the
effects of ET-1 on ICa,L were determined from currents measured
over a range of test potentials (500 ms commands were applied to
voltages between 230 and +50 mV from a holding potential of
240 mV). Figure 4A shows representative traces of ICa,L elicited
by depolarisation from 240 mV to +10 mV in the absence and
presence of ET-1, showing a marked suppression of peak current
amplitude by ET-1. Figure 4B shows mean current-voltage
relations for ICa,L in control and with ET-1. Repeated applications
of the ICa,L measurement protocol in the presence of ET-1 did not
lead to significant further reductions in current beyond that shown
in Figure 4A. A fit to the data with equation 1 yielded an
activation V0.5 of 22.760.6 mV in control and of 21.061.9 mV
in ET-1 (n=11 cells; p.0.1), whilst Gmax values derived from the
fits to the data were 0.3660.03 nS/pF (control) and
0.1660.03 nS/pF (ET-1; p,0.001). In 12 further experiments,
cells were exposed to the ETA receptor antagonist BQ-123 (1 mM)
prior to ET-1 application. Figure 4C shows mean I–V relations
from these experiments: with BQ-123 application prior to ET-1
superfusion, ET-1 did not reduce ICa,L amplitude at any
membrane voltage, implicating ETA receptor activation in this
action of ET-1. In 6 cells in which ICa,L at +20 mV was monitored
during ET-1 exposure and following washout, the inhibitory effect
of ET-1 was not reversed by washout.
Effects of ET-1 on rapid delayed rectifier K
+ current, IKr
The rapid delayed rectifier K
+ current, IKr, is important to
AVN AP repolarisation and can also influence spontaneous rate
[33,40–42]. IKr is typically measured from AVN cells as outward
tail current on repolarisation to a negative voltage following
depolarising voltage commands, and lacks contamination from
potentially overlapping currents such as IKs, which is absent from
rabbit AVN cells [33,41–44]. Accordingly, the effects of ET-1 on
IKr were assessed by measurements of outward tail current
amplitude at 240 mV, following 500 ms voltage commands to
more positive potentials (between 230 and +50 mV). Figure 5A
shows representative traces elicited following depolarisation to
+30 mV in the absence and presence of ET-1, with the inset
displaying the tails currents on a higher gain. ET-1 produced a
20–30% decrease in tail current amplitude. Figure 5B shows mean
I–V relations for IKr tails in control and at steady-state in ET-1
(n=5). Tail currents were significantly reduced at nearly all
potentials between 220 and +50 mV. A fit to the data with
equation 2 yielded activation V0.5 values of 215.763.6 and
20.764.3 mV in control and ET-1 respectively (p,0.05; n=5).
and 2100 mV. C. Mean I–V relationships for the instantaneous current recorded at the beginning of the test-pulse (Ci: in absence (control, filled
circles) and presence (open circles) of 10 nM ET-1). Cii shows I–V relation for the ET-1 activated instantaneous current (Cii, filled circles), in cells also
showing If (n=7). ET-1 activates a large inwardly rectifying current. D. I–V relations for If in presence of 1 mM BQ-123 (n=11) without (filled squares)
and with 10 nM ET-1 (open squares, n=11 at all potentials except at 250 mV, where n=10). BQ-123 prevented stimulation of If by ET-1. E. Inhibitory
effect of 1 mM BQ-123 on the ET-1 activated current in cells exhibiting showing If (open squares, n=12 except at 250 mV where n=11). Asterisks
denote statistical significance (p,0.001 ***).
doi:10.1371/journal.pone.0033448.g003
Effects of ET-1 on AVN Cell Electrophysiology
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33448Figure 4. Effects of ET-1 on the L-type Ca
2+ current (ICa,L). A. Representative records of ICa,L (upper traces) elicited at +10 mV from a holding
potential of 240 mV by protocol shown in lower traces, in both the absence (control) and presence of 10 nM ET-1. B. Plots of the mean I–V relations
for ICa,L (n=11), measured as peak - end pulse difference current, in control (filled circles) and with ET-1 (open circles): I–V curves were fitted using
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experiments on cells exposed to BQ-123 prior to ET-1. There
was no significant difference between BQ-123 alone and ET-1 in
the presence of BQ-123 in tail current at any test voltage,
implicating ETA receptor activation in mediating the suppressive
effect of ET-1 on IKr tail amplitude. Although ET-1 in the
presence of BQ-123 still appeared to produce some right-ward
shift in the fit to the current-voltage relationship (V0.5 of
212.065.1 mV in BQ-123 alone and 22.966.4 mV in BQ-123
and ET-1; n=5), due to cell-to-cell variability in response the
difference did not attain statistical significance (p.0.3). Similar to
ICa,L the effects of ET-1 on IKr did not reverse on ET-1 washout.
Investigation of the mechanism of AP quiescence
The rapid membrane potential hyperpolarisation with ET-1
during spontaneous AP recording shown in Figure 1 is consistent
with the activation of an outward current over the diastolic
membrane potential range. The ET-1 activated current observed
here (Figures 2 and 3) exhibited a voltage dependence reminiscent
of inwardly rectifying K
+ current in AVN cells activated by
acetylcholine (IK,ACh) or adenosine (IK,Ado), each of which exert
marked negative chronotropic effects on isolated AVN cells (e.g.
[28,30]). Tertiapin/tertiapin-Q have been shown previously to
inhibit sinoatrial IK,ACh (e.g. [45,46]) and to inhibit atrio-
ventricular block induced in the guinea-pig by IK,ACh activation
[47]. We hypothesised, therefore, that if ET-1 activates a current
similar to IK,ACh in AVN cells, tertiapin-Q should prevent rapid
ET-1 induced membrane potential hyperpolarisation and hyper-
polarisation-associated cell quiescence. Consequently, experiments
were performed in which tertiapin-Q was applied prior to ET-1
superfusion during spontaneous AP recording. Figure 6A shows
representative results. Application of 300 nM tertiapin-Q alone
did not alter spontaneous activity; however when ET-1 was
subsequently applied in the maintained presence of tertiapin-Q, no
rapid MDP hyperpolarisation or hyperpolarisation-associated
quiescence was induced. Instead, there was a gradual depolarisa-
tion of MDP and decrease in AP amplitude (this cell depolarised
and became quiescent within ,30 seconds of ET-1 in the
presence of tertiapin-Q). Similar experiments were performed on
seven spontaneously active cells; in none of them did ET-1 induce
membrane potential hypolarisation in the presence of tertiapin-Q.
Experiments were then performed to determine whether or not
tertiapin-Q also inhibited ET-1 activated current under voltage
clamp. Figure 6C shows that, in the presence of tertiapin-Q, ET-1
was unable to activate any inwardly rectifying instantaneous
current. In a further 7 experiments, a second known inhibitor of
inwardly rectifying ACh-activated K
+ conductances, Ba
2+ ions,
was applied (at 2 mM; [48]) during repetitive application of a
descending voltage-ramp protocol. Ba
2+ rapidly inhibited the ET-
1 activated current in all cells tested (not shown). Collectively, the
results of these experiments implicate ET-1 activation of an
IK,ACh-like current in the rapid suppression of spontaneous activity
shown in Figure 1.
ET-1 effects on all currents observed under voltage-clamp were
sensitive to ETA receptor inhibition (Figures 2, 3, 4, and 5).
Therefore, additional spontaneous AP recordings were performed
in which the ETA receptor inhibitor BQ-123 was applied prior to
ET-1 superfusion. Figure 7 shows the results from one of six
similar experiments. When ET-1 was applied following exposure
of cells to BQ-123 no rapid membrane potential hyperpolarisation
or suppression of spontaneous activity was observed. In a final set
of experiments, the effects of a selective ETB receptor agonist,
IRL-1620 were investigated. IRL-1620 produced a small depo-
larisation of MDP (by 5.261.4 mV; n=5) and decrease in AP
overshoot (a mean reduction of 14.161.4 mV; see Figure 8);
however, no cell tested responded to IRL-1620 with membrane
potential hyperpolarisation or quiescence. In contrast, when ET-1
was applied in the maintained presence of IRL-1620 it produced
rapid membrane potential hyperpolarisation and quiescence
(similar to that seen when ET-1 alone was applied; Figure 1).
Discussion
Placing novel findings in context
To our knowledge, the present data are the first to demonstrate
directly modulation by ET-1 of AVN electrophysiology. Previous-
ly, intravenous administration of BQ-123 to anaesthetised pigs
and, via intracoronary injection, to a small sample of human
patients with coronary artery disease has been reported not to alter
AV nodal conduction [49,50], suggestive of a lack of effect of basal
endogeneous ET-1 on AV nodal conduction via ETA receptors in
those studies. On the other hand, intracoronary bolus injection of
ET-1 to anesthetized dogs [26,27] and rats [26,27] has been
shown to produce AV block, which is suggestive of an ability of
increased ET-1 levels to modulate AVN electrical behaviour. The
results of the present study show that ET-1 can suppress AVN
cell activity, and the modulatory effects on AVN cellular
electrophysiology seen here may help explain prior observations
of ET-1 induced AV block [26,27]. This is also the first study to
demonstrate tertiapin-Q sensitivity of an ET-1 activated K
+
current in any cell or tissue type. Several features of our findings
merit more detailed discussion.
Comparison with previous studies
Whilst the effects of ET-1 on cardiac ion channel currents from
other cardiac cell types have been widely studied, the most
relevant data for comparison with the present study come from
prior investigations of isolated sinoatrial node (SAN) cell and tissue
preparations [21–23]. In 2001 Ono and colleagues demonstrated
negative chronotropic effects of ET-1 on rabbit intact SAN
preparations and isolated SAN cells [23]. Application of ET-1 at
the same concentration used in the present study (10 nM) was able
to induce quiescence in isolated SAN cells, which either did not
readily reverse or reversed incompletely during the recording
measurement period. However, the negative chronotropic effect of
ET-1 seen in that study was accompanied by membrane potential
hyperpolarisation only in some (rod-shaped) cells, whilst other
(spindle-shaped) cells showed depolarisation of the MDP [23]. A
separate study of rabbit SAN cells by Tanaka and colleagues
produced results in good agreement with those in the present
investigation: application of 10 nM ET-1 routinely led rapidly to
cessation of spontaneous activity and to membrane potential
hyperpolarisation [21]. In the present study, all spontaneously
active AVN cells exposed to ET-1 exhibited rapid membrane
equation 1 (Methods) to give V0.5 values of 22.760.6 mV in control and 21.061.9 mV in ET-1 (p.0.1). Corresponding k values were 7.160.5 mV and
6.561.7 mV in control and ET-1, respectively (p.0.7). C. I–V relations (n=12) for ICa,L in the presence of 1 mM BQ-123 (filled squares) and when 10 nM
ET-1 was applied in the maintained presence of BQ-123 (open squares). V0.5 values were 2.161.1 mV and 1.061.0 mV respectively for BQ-123 and BQ-
123+ET-1 (p.0.4), with corresponding k values of 8.260.9 mV and 7.460.9 mV (p.0.5). Asterisks in ‘B’ denote statistical significance (p,0.01 **,
p,0.001 ***).
doi:10.1371/journal.pone.0033448.g004
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33448Figure 5. Effects of ET-1 on rapid delayed rectifier K
+ current tails. A. Upper traces show currents elicited on depolarisation to +30 mV and
subsequent repolarization to 240 mV by protocol shown in lower trace. Deactivating tail currents on repolarization represent the IKr ‘tail’. Currents
are shown in control solution and in presence of 10 nM ET-1. Insert shows an expanded portion of the traces to highlight the ‘tail’ currents (the
horizontal arrow in the inset denotes the zero current level). B. Mean ‘tail’ current I–V relationships for 5 cells, in absence (control, filled circles) and
Effects of ET-1 on AVN Cell Electrophysiology
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33448presence (open circles) of 10 nM ET-1. I–V curves were fitted with equation 2 (Methods) to derive V0.5 values of 215.763.6 mV in control and
20.764.3 mV in ET-1 (p,0.05), with respective k values of 6.462.6 mV and 6.963.9 mV (p.0.9). The ‘tail’ current was significantly reduced in
presence of ET-1 at all voltages ranging from 220 to +50 mV except +20 mV. C. Mean I–V plots for IKr tails in the presence of 1 mM BQ-123 without
(filled squares; n=5) and with 10 nM ET-1 (open squares, n=5 for all, except at +40 and +50 mV where n=4). Derived V0.5 values were
212.065.1 mV and 22.966.4 mV for BQ-123 and BQ-123+ET-1, respectively (P.0.3), with associated k values of 4.964.4 and 8.465.8 (p.0.6).
Asterisks in B denote statistical significance (p,0.05 *, p,0.01 **, p,0.001 ***).
doi:10.1371/journal.pone.0033448.g005
Figure 6. Effects of tertiapin-Q (TQ) on the effect of ET-1 on spontaneous APs and ET-1 activated current. A. Continuous recording of
spontaneous activity in control, in the presence of TQ (300 nM) before and with application of 10 nM ET-1 in the maintained presence of TQ. Note the
absence of immediate hyperpolarisation and cessation of APs evident in Figure 1. Bi, ii and iii show expanded records from recording in A, at time-
points indicated: i taken during control, ii near the end of TQ alone and iii is taken at ,13 seconds of ET-1 application (at which time-point cells
exposed to ET-1 alone had hyperpolarised and become quiescent). Similar results were obtained from 7 cells. C. Mean I–V relationships for the 10 nM
ET-1 activated instantaneous current in absence (filled triangles, n=14) and in presence of 300 nM TQ (open triangles, n=7. except at 280 mV where
n=6). TQ prevented this action of ET-1. Asterisks in C denote statistical significance (p,0.05 *, p,0.001 ***).
doi:10.1371/journal.pone.0033448.g006
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from both SAN studies indicated a marked inhibitory action of
ET-1 on ICa,L (,50% inhibition at 10 nM ET-1) [21,23] which is
in reasonable agreement with our own observations for AVN cells.
This contrasts with more modest effects of ET-1 on guinea-pig
ventricular ICa,L (,21% inhibition of basal ICa,L by 20 nM ET-1
[51] and human ventricular ICa,L (,33% inhibition of basal ICa,L
by 8 nM ET-1 [52]). Such differences may be accounted for by
regional and/or species differences in ET-1 response, with rabbit
primary and secondary pacemaker cell types exhibiting a greater
response than ventricular myocytes from these two other species.
The possibility of regional differences in response is supported by
results from a study of rabbit ventricular myocytes [36] that
reported weak bi-phasic effects of 10 nM ET-1 on basal ICa,L, with
an inhibitory effect of smaller magnitude (,20%) than those seen
for AVN (this study) or SAN [21,23]. Ono and colleagues also
reported a modest reduction in delayed rectifier (IK) tails across a
wide range of voltages for spindle-shaped cells and up for voltages
up to ,0 mV for rod-shaped cells, accompanied in both SAN
types by positively shifted (,+5–+14 mV) IK activation [23].
Tanaka and colleagues also showed suppression of SAN IK by ET-
1, though they did not study the voltage-dependence of the effect
[21]. The activation V0.5 values under control conditions for the
tail currents investigated in this study are within the range
reported previously for AVN IKr [33,41]. Although, in contrast
with rabbit AVN cells that exhibit only IKr [33,41–44], both IKr
and IKs have been seen in rabbit SAN cells [43,53], the activation
characteristics of the current sensitive to ET-1 in the study of Ono
and colleagues [23] are concordant with a primary identity as IKr.
Both the present study and that of Ono and colleagues [23] report
right-shifted current activation with ET-1, suggesting modification
of a similar current in each case. Consequently, it is highly likely
that, as reported previously for human ventricular IKr [52], ET-1
inhibits IKr from both secondary and primary pacemaker cell
types.
Previously reported effects of ET-1 on If from SAN cells show
some differences from those observed here for AVN myocytes.
Thus, Ono and colleagues reported that 10 nM ET-1 activated If
between ,275 and 285 mV, but that it inhibited If at more
negative voltages [23]; Tanaka and colleagues also reported an
inhibitory action [22]. On the other hand, we saw significant
augmentation of AVN cell If by ET-1, but only at potentials
negative to the diastolic potential range. Similar to previous studies
conducted under comparable recording conditions [29,33], If from
AVN cells under control conditions here was small or absent over
the diastolic potential range and the lack of any statistically
significant effect of ET-1 at potentials positive to 2100 mV makes
it unlikely that modulation of If by ET-1 contributed significantly
to effects seen under AP recording conditions. By contrast, the
activation of an inwardly rectifying K
+ current, with significant
ET-1 activated outward current between ,240 and 280 mV is
of central importance to the overall actions of ET-1 seen here. The
ability of ET-1 to activate a current with similar properties to the
muscarinic potassium current (IK,ACh) was first demonstrated for
non-pacemaker cardiac cells [54,55], although some studies have
demonstrated an ability of ET-1 to inhibit IK,ACh and IK,Ado (e.g.
[56–58]). Tanaka and colleagues demonstrated activation by ET-1
in rabbit SAN cells of an inwardly rectifying K
+ current similar to
that seen here, also showing this to be Ba
2+-sensitive and to carry
outward current over potentials relevant to the diastolic potential
range [21]. Drici and colleagues have demonstrated that ACh-
induced AV block in guinea-pig hearts is prevented by tertiapin at
Figure 7. BQ-123 inhibition of the effects of ET-1 on spontaneous APs. A. Continuous recording of spontaneous activity in control solution,
in presence of 1 mM BQ-123 before and during subsequent superfusion of 10 nM ET-1 in the maintained presence of BQ-123. BQ-123 prevented the
ET-1 induced cessation of spontaneous APs and associated membrane potential hyperpolarisation. Bi, ii and iii show expanded extracts of the
recording in A, at the time-points indicated: i taken during control, ii near the end of BQ-123 alone and iii is taken at ,13 seconds of ET-1 application
in the presence of BQ-123 (at which time-point cells exposed to ET-1 alone had hyperpolarised and become quiescent). Similar results were obtained
in 6 cells.
doi:10.1371/journal.pone.0033448.g007
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effects of tertiapin on other important cardiac ionic currents [47].
Thus, the inhibition by tertiapin-Q of the ET-1 activated (Ba
2+-
sensitive) inwardly rectifying current in AVN cells seen here
identifies the underlying channels as similar to those that mediate
IK,ACh. It is also notable that activation of a similar K
+ current
(IK,Ado) contributes significantly to the known negative chrono-
tropic and dromotropic effects of adenosine [30,59]. Moreover, it
is evident from the complete lack of membrane potential
hyperpolarisation when ET-1 was applied to cells treated with
tertiapin-Q, that this current mediated the rapid hyperpolarisation
and quiescence of AVN cells following ET-1 application. IK,ACh
from the SAN has been shown to exhibit a time-dependent fade in
the presence of continued muscarinic receptor activation as a
result of desensitization [60,61] and our results indicate that a
similar phenomenon occurs for ET-1 activated inwardly rectifying
K
+ current in AVN cells. The mechanism underlying this effect
remains to be elucidated and warrants future study. The
progressive MDP depolarisation and decrease in AP amplitude
seen when ET-1 was applied to tertiapin-Q treated cells can be
explained, wholly or in part, by ET-1 inhibition of IKr (which
would predispose towards membrane potential depolarisation) and
of ICa,L (which would decrease AP amplitude and may also offset
AP prolongation anticipated with pure IKr inhibition), neither of
which response showed time-dependent fade. Similarly, the
persistence of an ET-1 effect following ET-1 washout, namely
maintained quiescence and progressive membrane potential
depolarisation (Figure 1), can be accounted for by continued
ET-1 receptor activation following washout and by the peptide’s
effects on IKr/ICa,L predominating as the inwardly rectifying
current response became desensitized/faded. Our data in this
regard are compatible with previously reported quasi-irreversible
binding of ET-1 to cardiac myocytes ET (ETA) receptors and on
ET-receptor mediated signalling [39].
A central role for ETA receptors
Autoradiographical examination of the human cardiac conduc-
tion system has demonstrated the presence of both ETA and ETB
receptors in the AVN and atrio-ventricular conduction system [24],
with a higher proportion of ETB receptors and lower proportion of
ETA receptorsintheAVconductionsystemthan inthesurrounding
interventricular and interatrial septa [24]. mRNA for both ET
Figure 8. Effect of IRL-1620 on spontaneous APs. A. Slow time-base continuous recording of APs in control conditions, followed by the
application of 300 nM IRL-1620 and following addition of 10 nM ET-1 in the maintained presence of IRL-1620. IRL-1620 did not abolish the
spontaneous APs, whereas application of 10 nM ET-1 stopped spontaneous activity and hyperpolarized the membrane potential. Similar results were
acquired in 5 cells. Bi, ii, iii and iv show expanded extracts of the recording shown in A, at the time-points indicated: i taken during control, ii and iii
taken respectively mid-way and towards the end of IRL-1620 alone and iv is taken at ,13 seconds of ET-1 application in the presence of IRL-1620 (at
which time-point cells exposed to ET-1 alone had hyperpolarised and become quiescent).
doi:10.1371/journal.pone.0033448.g008
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heart [23], with mRNA levels for ETB in the SAN suggested to be
similar to those in atria and ventricles, whilst those for ETA have
suggested to be lower [23]. Against this background, it is notable
that effects of ET-1 on SAN action potentials and ionic currents
have been reported to be highly sensitive to ETA receptor blockade
[21,23]. Inhibitory effects of ET-1 on SAN ICa,L and IK and the
activation of IK,ACh-like inward rectifier current were all abolished
by selective ETA blockade [21]. Our data provide strong evidence
for a similar pivotal role for ETA receptor involvement in ET-1
modulation of AVN cell activity, both at the level of effects on
spontaneous APs and also for ionic currents. It is particularly
notable that application of the ETB-selective agonist IRL-1620
failed to replicate the rapid membrane potential hyperpolarisation
and quiescence produced by ET-1 (and inhibited by BQ-123);
whilst subsequent ET-1 application in the maintained presence of
IRL-1620 led rapidly to these effects. This indicates that the
dominant, rapid-onset effect of ET-1 under our conditions was
activation of tertiapin-Q sensitive IK,ACh-like current, mediated
through ETA receptors. Our data do not preclude entirely potential
roles for ETB receptor activation: application of IRL-1620 itself led
to a modest reduction in AP magnitude and, under voltage-clamp,
of ICa,L (data not shown). Whether or not these actions of IRL-1620
are mediated through ETB receptor activation per se or represent a
non-selective action of this agent is unclear at this time. Efforts to
pursue this line further through the use of a selective ETB receptor
antagonist, RES-701, were confounded by potential contaminating
effects that led us to abandon its use. Nevertheless, what is very clear
from our experiments is the dominant role played by ETA receptor
activation in the observed effects of ET-1, which is in good
agreement with prior work on the SAN.
Limitations, future work and conclusions
Understanding of the cellular electrophysiology of the AVN and
its modulation has tended to lag behind that of other cardiac
regions, to a significant extent likely due to challenges inherent in
isolating and working with single AVN cells. Accordingly, the
present study is the first to characterise major actions of ET-1 on
AVN APs and ionic currents and has identified a number of
marked effects. However, whilst our voltage-clamp data can
account for the principal effects of ET-1 seen on spontaneous
AVN APs, this does not mean that the basis for all modulatory
effects have yet been identified. For example, the underlying basis
for the small amplitude spontaneous membrane potential
oscillations in quiescent AVN cells following ET-1 treatment
(Figure 1) remains to be elucidated. Recent data indicate that
AVN activity is influenced by cellular Ca
2+ cycling, likely through
the interaction between Ca
2+ released from internal stores and the
sarcolemmal Na-Ca exchanger (NCX) [10,62,63]. ET-1 has been
reported to stimulate NCX activity [64,65] and the effects of ET-1
on AVN NCX remain to be investigated. Additionally, it is well
established that in atrial myocytes ET-receptor activation of IP3
receptors can influence Ca
2+ mobilization (e.g [66–68]) and IP3
receptor activity has recently been proposed to modulate murine
SAN activity [69]. Thus, potential additional effects of ET-1 on
AVN activity mediated by the modulation of Ca
2+ handling merits
future enquiry. The experimental concentration of ET-1 used in
this study (10 nM) lies within the range used in previous rabbit
SAN and ventricular cardiomyocyte studies (1–100 nM; e.g.
[21,23,36]) and is similar to that (8 nM) used to study ET-1
effects on undiseased human ventricular myocytes [52]. It should
be noted that, whilst normal plasma levels of ET-1 are low (in the
fM-pM range; e.g. [70,71]), considerably higher pericardial and
tissue levels can be measured (e.g. [71,72]). We are not aware of
data on endogenous ET-1 levels in AVN tissue per se, but a level of
,1.2 nM has been measured in rabbit left ventricle [71], whilst in
human atrial tissue a mean level of ,19 nM (range ,2–64 nM)
has been measured [72]. Thus, whilst the ET-1 concentration used
in this (and other) studies is likely to exceed circulating plasma
levels, it lies within measured cardiac tissue levels [71,72].
Additional avenues of future investigation opened by the present
report include the determination of effects of wide-ranging ET-1
concentrations (cf [21]), the study of intracellular pathways
mediating major identified effects, and investigation of effects of
ET-1 on autonomic agonist modulation of AVN activity.
To summarise and conclude: the present study demonstrates for
the first time that ET-1 activation of ETA receptors produces a
rapid suppression of spontaneous activity of rabbit AVN cells. ET-
1 also inhibits both IKr and ICa,L from AVN cells whilst activating
K
+ current through channels identical to those responsible for
muscarinic inwardly rectifying K
+ current. This current mediates
the initial rapid hyperpolarisation and quiescence produced by
ET-1, whilst IKr and ICa,L suppression are likely to contribute to
maintained suppression of excitability. Bolus injection of ET-1 in
previous experimental studies on anaesthetised animals [26,27] is
likely to have produced a rapid, local rise in ET-1 in blood
perfusing the AVN. Rapid membrane potential hyperpolarisation
through activation of an IK,ACh-like current and suppression of
currents important to AVN AP genesis can account for the AV
block subsequently observed in those studies [26,27] - a
proposition that can be tested further through future targeted
experiments using intact AVN preparations.
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